KENDALL HENRY: Open Payments
NPI 1598361321 · LA CANADA FLINTRIDGE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,668 in 41 payments from 16 companies in 2025. Trend: 2023 $526 · 2024 $473 · 2025 $1,668
Food & beverage: $1,668
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 4 | $311 |
| Journey Medical Corporation | 2 | $250 |
| UCB, Inc. | 4 | $206 |
| Regeneron Healthcare Solutions, Inc. | 4 | $183 |
| Incyte Corporation | 10 | $177 |
| E.R. Squibb & Sons, L.L.C. | 1 | $117 |
| Janssen Biotech, Inc. | 1 | $100 |
| Amgen Inc. | 3 | $58 |
| LEO Pharma Inc. | 3 | $57 |
| MIMEDX Group, Inc. | 2 | $37 |
Products named: NEMLUVIO, Bimzelx, DUPIXENT, OPZELURA, EMROSI, Sotyktu, TREMFYA, OTEZLA.
Industry payments across CA — which companies pay providers there.
